跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ivab-5
Approved
STANDARD
Ivab-5
Bafna Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d2b1d6ed6a15ff80
Company
Bafna Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
d2b1d6ed6a15ff80
Drug Approval Philippines Name
Ivab-5
Product Name
Ivab-5
Registration Number
DRP-16393
Brand Name
Ivab-5
Generic Name
Ivabradine (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
5mg
Manufacturer
Bafna Pharmaceuticals Limited
Issuance Date
26 February 2025
Expiry Date
26 February 2030
Pharmacologic Category
Anti-angina
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d2b1d6ed6a15ff80
Type
Standard
Back to Philippines FDA Approvals
Ivab-5 - Philippines FDA Drug Approval Details